Kerecis Ltd.
🇺🇸United States
Clinical Trials
13
Active:4
Completed:6
Trial Phases
3 Phases
Early Phase 1:1
Phase 4:2
Not Applicable:6
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Not Applicable
6 (66.7%)Phase 4
2 (22.2%)Early Phase 1
1 (11.1%)Evaluating the Durability of Closure for Venous Leg Ulcers
Recruiting
- Conditions
- Venous LegVenous Leg Ulcer (VLU)Venous Leg UlcerVenous UlcerVLU
- First Posted Date
- 2024-11-20
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Kerecis Ltd.
- Target Recruit Count
- 150
- Registration Number
- NCT06697925
- Locations
- 🇺🇸
Serena Group, Monroeville, Pennsylvania, United States
Evaluating Intact Fish Skin Graft and Standard of Care Versus Standard of Care Alone in Nonhealing Venous Leg Ulcers
Phase 4
Recruiting
- Conditions
- Venous Leg Ulcer (VLU)Venous Leg UlcersVenous LegNonhealing Venous Leg Ulcer
- First Posted Date
- 2024-11-18
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Kerecis Ltd.
- Target Recruit Count
- 150
- Registration Number
- NCT06693570
- Locations
- 🇺🇸
Serena Group- Monroeville, Monroeville, Pennsylvania, United States
Kerecis Real-World Fish Skin Graft Registry
- Conditions
- WoundsDiabetic Foot UlcerSurgical WoundSoft Tissue ReinforcementPressure UlcerVenous Leg Ulcer
- First Posted Date
- 2024-04-25
- Last Posted Date
- 2024-12-30
- Lead Sponsor
- Kerecis Ltd.
- Target Recruit Count
- 600
- Registration Number
- NCT06384183
- Locations
- 🇺🇸
Cone Health Ortho Care Greensboro, Greensboro, North Carolina, United States
🇺🇸Feet First Institute of Beavercreek, Beavercreek, Ohio, United States
🇺🇸ABC Podiatry, Columbus, Ohio, United States
AFS Compared to AHC in Treatment of Necrotizing Fasciitis NF
Phase 4
Active, not recruiting
- Conditions
- Necrotizing Fasciitis
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2024-12-30
- Lead Sponsor
- Kerecis Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT06073301
- Locations
- 🇺🇸
Joseph M. Still Research Foundation, Augusta, Georgia, United States
Kerecis Case Registry for SurgiBind : Soft Tissue Reinforcement
Active, not recruiting
- Conditions
- Surgery-Complications
- First Posted Date
- 2023-06-12
- Last Posted Date
- 2024-12-31
- Lead Sponsor
- Kerecis Ltd.
- Target Recruit Count
- 200
- Registration Number
- NCT05898711
- Locations
- 🇺🇸
Kerecis, Arlington, Virginia, United States
- Prev
- 1
- 2
- 3
- Next
News
No news found